OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion

Objective: To determine the percentage of patients given standard doses of piperacillin/tazobactam or meropenem by continuous infusion who achieved the target pharmacokinetic/pharmacodynamic (PK/PD) index, which was defined as free concentrations four times more than the minimum inhibitory KEYWORDS...

Descripción completa

Detalles Bibliográficos
Autores: Esteve Pitarch, Erika, Padullés Zamora, Ariadna, Maisterra-Santos, Kristel, Colom Codina, Helena, Cobo Sacristán, Sara
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/175294
Acceso en línea:https://hdl.handle.net/2445/175294
Access Level:acceso abierto
Palabra clave:Antibiòtics betalactàmics
Medicina intensiva
Farmacocinètica
Beta lactam antibiotics
Critical care medicine
Pharmacokinetics
Descripción
Sumario:Objective: To determine the percentage of patients given standard doses of piperacillin/tazobactam or meropenem by continuous infusion who achieved the target pharmacokinetic/pharmacodynamic (PK/PD) index, which was defined as free concentrations four times more than the minimum inhibitory KEYWORDS Beta-lactams; Critical care; Pharmacokinetics; Drug monitoring; Piperacillin; Meropenem.